ICAM1 and leukemia: The authors found that TGF-β significantly decreased NK cell killing of leukemia cell lines secondary to leukemia cell downregulation of the NK cell ligand CD48 as well as decreased ICAM-1 binding affinity resulting in impaired effector-target interaction [201].